Fenofibrate in Type 2 Diabetes- Novel Biomarkers and Mechanisms Save

Date Added
August 21st, 2018
PRO Number
Pro00079289
Researcher
Timothy Lyons

List of Studies

Silhouette
Keywords
Diabetes
Summary

People with diabetes develop irreversible eye, kidney, and nerve damage that is difficult to treat. Recent studies show that fenofibrate, a safe drug that has been used to lower cholesterol in the past, is effective in eye and kidney disease in patients with diabetes; but it is unclear how the drug actually works. We will do a ?proteomic' analysis, a technology that measures hundreds of proteins in the blood, in 40 patients with diabetes before and after they take fenofibrate for six weeks. This work will help us understand how exactly the drug works, so that better treatment and preventive methods can be developed for the complications of diabetes.

Institution
MUSC
Recruitment Contact
Misti Leyva
8437921933
leyva@musc.edu

Change_preferences

-- OR --

Create_login